Stay updated with breaking news from John Fraser Wright. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Proceeds will be used to advance clinical program of GNSC-001, company's lead candidate in osteoarthritis (OA) Brian Kotzin, M.D., and Jackson Streeter, M.D.,...
A TWENTY five year old man who assaulted another man and then brandished a knife at police officers has been handed a two-year community payback order. John Fraser Wright, of Lerwick’s Observatory, admitted assaulting the man and repeatedly striking him on the head with a...
Share this article PALO ALTO, Calif., May 5, 2021 /PRNewswire/ -- Genascence Corporation, a clinical-stage biotechnology company developing life-changing gene therapy products for prevalent musculoskeletal diseases, today announced that dosing across all three cohorts has been completed in the Phase 1 clinical trial of GNSC-001 for the treatment of osteoarthritis (OA). GNSC-001 is an adeno-associated vector (AAV) carrying a coding sequence for interleukin-1 receptor antagonist (IL-1Ra), a potent inhibitor of interleukin-1 (IL-1) signaling. IL-1 is considered one of the key mediators involve...